Guangzhou Baiy | 600332 - Selling And Administration Expenses

Stock Price
22.52
Daily Change
-0.16 -0.71%
Monthly
-3.22%
Yearly
-13.38%
Q2 Forecast
22.07

Guangzhou Baiy reported CNY2.23B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Jiangsu Hengrui CNY 2.81B 191.05M Mar/2026
Kalbe Farma IDR 2.51T 410.17B Sep/2025
Richter Gedeon HUF 52.3B 6.68B Sep/2025
Sh Fosun Pharma CNY 4.44B 1.32B Dec/2025
Sh Pharmaceutical CNY 5.03B 372.15M Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025